Intersect Capital

Intersect Capital’s Sonnet BioTherapeutics SONN Stock Holding History

Intersect Capital’s Portfolio SONN Stock Details SONN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Hold	0	–	-$21K	–	176
2019 Q1	–	Hold	0	–	–	–	142
2018 Q4	–	Hold	0	–	–	–	128
2018 Q3	–	Hold	0	–	–	–	128
2018 Q2	–	Hold	0	–	–	–	126
2018 Q1	–	Hold	0	–	–	–	118
2017 Q4	–	Hold	0	–	–	–	115
2017 Q3	–	Hold	0	–	–	–	110
2017 Q2	–	Hold	0	–	–	–	108
2017 Q1	–	Hold	0	–	–	–	87
2016 Q4	–	Hold	0	–	–	–	94
2016 Q3	–	Hold	0	–	–	–	91
2016 Q2	–	Hold	0	–	–	–	107
2016 Q1	–	Hold	0	–	–	–	105
2015 Q4	–	Hold	0	–	–	–	91
2015 Q3	–	Hold	0	–	–	–	90

Other funds holding SONN

Anson Funds Management

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quad-Cities Investment Group

Quad-Cities Investment Group Davenport, Iowa $280M AUM 15.19% 1-Year Est. Return